Acupuncture for Mucositis Pain in Cancer Care
Mucositis, Pain, Leukemia
About this trial
This is an interventional supportive care trial for Mucositis focused on measuring mucositis pain, cancer, pain, acupuncture, mucositis, cancer pain
Eligibility Criteria
Inclusion Criteria:
- Newly diagnosed with leukemia (such as acute myelogenous leukemia) and receiving chemotherapy for induction, consolidation or re-induction or high dose preparative regimen for bone marrow transplantation in the Johns Hopkins Oncology Inpatient Services
- Participation in standard leukemia-treatment regimens
- Expectation of survival of three weeks for completion of the study
Exclusion Criteria:
- Acupuncture treatment within the previous 6 weeks
- Unable to achieve platelet count of at least 10,000 with platelet support
- Radiation therapy within one month of enrollment
- Pregnant women
- History of substance abuse, including alcohol and IV drug users
Sites / Locations
- Johns Hopkins Medical Institutions
Arms of the Study
Arm 1
Arm 2
Active Comparator
Sham Comparator
Real Acupuncture
Sham Acupuncture
Participants will have acupuncture performed at a rate of 3 times (Mon, Wed, Fri) / week for total of 2 weeks (total of 6 sessions). We will follow Saam Acupuncture methods, which have been the mainstream of acupuncture methodology in most Korean Oriental Medical Colleges and among clinical practitioners >400 years. Standardized acupuncture prescriptions for mucositis will be acupuncture points tonifying Spleen Meridian (R side) and Small Intestine Meridian (L side). In Oriental Medicine, the spleen has functions of promoting water metabolism, transporting nutrients, and controlling blood. Mouth belongs to the spleen system according to Five element theory. Small intestine is related with mucositis symptoms including thirst and tongue ulcers. We will use sterile, disposable, filiform needles, size 0.16 (40Gauge) - 0.30 mm (30Gauge) in diameter and 15-40 mm long. Total number of acupuncture needles will be 8 (4 needles each side) and needles will be retained for 20 minutes.
Newly diagnosed leukemia patients will be recruited from the large patient population on the Leukemia Inpatient Services who will be receiving high dose preperative regimens such as Busulfan + Cytarabine for marrow transplantation.